FANELLI, GIUSEPPE NICOLO'
 Distribuzione geografica
Continente #
NA - Nord America 1.612
AS - Asia 1.332
EU - Europa 1.084
SA - Sud America 314
AF - Africa 97
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.444
Nazione #
US - Stati Uniti d'America 1.510
IT - Italia 522
SG - Singapore 463
HK - Hong Kong 301
CN - Cina 292
BR - Brasile 258
DE - Germania 130
SE - Svezia 100
GB - Regno Unito 78
CA - Canada 77
VN - Vietnam 57
CI - Costa d'Avorio 44
IN - India 44
FI - Finlandia 41
AT - Austria 37
BD - Bangladesh 34
NL - Olanda 34
RU - Federazione Russa 34
FR - Francia 31
AR - Argentina 22
JP - Giappone 22
PL - Polonia 21
TR - Turchia 17
BG - Bulgaria 15
KR - Corea 15
PK - Pakistan 15
MX - Messico 14
SA - Arabia Saudita 14
EC - Ecuador 12
MA - Marocco 12
ZA - Sudafrica 11
IQ - Iraq 8
SN - Senegal 8
VE - Venezuela 8
ID - Indonesia 7
NG - Nigeria 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CO - Colombia 5
ES - Italia 5
KE - Kenya 5
LT - Lituania 5
RO - Romania 5
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
EG - Egitto 4
KZ - Kazakistan 4
PY - Paraguay 4
UA - Ucraina 4
DO - Repubblica Dominicana 3
GR - Grecia 3
IE - Irlanda 3
IR - Iran 3
MY - Malesia 3
UY - Uruguay 3
BB - Barbados 2
BZ - Belize 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JO - Giordania 2
LB - Libano 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
CM - Camerun 1
DK - Danimarca 1
DZ - Algeria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
ML - Mali 1
MW - Malawi 1
PE - Perù 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.444
Città #
Hong Kong 297
Singapore 277
Ashburn 254
Dallas 245
Santa Clara 230
Shanghai 115
Pisa 85
Chandler 76
New York 71
Los Angeles 69
Munich 69
Boardman 57
Toronto 56
Milan 54
Beijing 52
Florence 45
Abidjan 44
London 37
Rome 34
Princeton 30
Lawrence 29
Buffalo 26
Vienna 26
Fairfield 25
Frankfurt am Main 25
Hefei 24
São Paulo 24
Turku 23
Medford 19
Redondo Beach 18
Amsterdam 17
Tokyo 16
Ho Chi Minh City 15
Sofia 15
Denver 14
Lucca 14
Warsaw 14
Houston 13
Seoul 13
Chennai 12
Rio de Janeiro 12
Wilmington 12
Cascina 11
Chicago 11
Hanoi 11
San Francisco 11
Orem 10
Riyadh 10
Vicopisano 10
Bari 9
Helsinki 9
Nuremberg 9
Ogden 9
Brescia 8
Dakar 8
Dhaka 8
Istanbul 8
Lappeenranta 8
Montreal 8
Poplar 8
Fuzhou 7
San Diego 7
Seattle 7
Woodbridge 7
Baku 6
Lagos 6
New Delhi 6
Phoenix 6
Quanzhou 6
Quito 6
Baghdad 5
Barletta 5
Bremen 5
Cambridge 5
Düsseldorf 5
Indianapolis 5
Johannesburg 5
Monte Argentario 5
Nairobi 5
Nottingham 5
Osaka 5
Palo del Colle 5
Salvador 5
Suzhou 5
Tashkent 5
Ankara 4
Atlanta 4
Bonn 4
Casablanca 4
Dubai 4
Genoa 4
Haiphong 4
Karachi 4
Lauterbourg 4
Portsmouth 4
Queens 4
Torino 4
Vico del Gargano 4
Viçosa 4
Acquaviva Delle Fonti 3
Totale 2.967
Nome #
Macrophage Polarization and Prognostic Implications in Glioblastoma 244
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 213
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine 192
Cervical Adenocarcinoma: A Still Under-investigated Malignancy 136
Tumour stroma characterization for the clinical stratification of HR+/HER2- breast cancer 130
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 123
Decipher the glioblastoma microenvironment: The first milestone for new groundbreaking therapeutic strategies 115
Immunohistochemistry for thymidine kinase-1 (Tk1): A potential tool for the prognostic stratification of breast cancer patients 114
Is it time to consider the Androgen receptor as a therapeutic target in breast cancer? 108
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 105
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series 105
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw 102
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 100
Cervical Adenocarcinoma: A Still Under-investigated Malignancy 97
New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes 97
Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization 96
Stem cells for treatment of cardiovascular diseases: An umbrella review of randomized controlled trials 86
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 85
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer 83
Value of Artificial Intelligence in Evaluating Lymph Node Metastases 80
Shedding light on PRAME expression in dysplastic nevi: a cohort study 78
Metabolomics of prostate cancer gleason score in tumor tissue and serum 78
Follicular melanoma—A rare entity: First description of an association with a nevus 76
Epidemiology of Merkel cell carcinoma in Tuscany (Italy), 2006-2021 76
Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component 73
Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants 71
Prostate stromal transcriptome as biomarker of aggressive prostate cancer 68
Genetic, epigenetic, and immunologic profiling of MMR-deficient relapsed glioblastoma 65
Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity 64
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases (Cancer Cell International (2018) 18 (131) DOI: 10.1186/s12935-018-0634-8) 61
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 60
Distinct mesenchymal cell states mediate prostate cancer progression 59
A Metastatic Squamous Cell Carcinoma in a Diabetic Foot: Case Report 58
LONG-NONCODING RNAs in gastroesophageal cancers 56
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 55
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 54
CD80/CD163 macrophage signature identifies high-risk glioblastoma patients 53
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma 53
MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions 53
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status 52
Pre-Implantation Kidney Biopsies in Extended Criteria Donors: From On Call to Expert Pathologist, from Conventional Microscope to Digital Pathology 51
Cerebral Lymphoproliferation in a Patient with Kabuki Syndrome 51
Calcific myonecrosis of the leg: A rare entity 51
Rosai-Dorfman Disease: Case Report of an Unusual Testicular Involvement and Review of Literature 50
Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition 46
Insights from Multigene Panel Sequencing and Comparative Analysis of Metaplastic Carcinoma of the Breast 46
PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions 45
Mesenchymal cell populations associated with different stages of prostate cancer progression in mice and human 44
Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol 42
Ovarian teratoma or uterine malformation? PET/MRI as a novel useful tool in NMDAR encephalitis 42
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 42
Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring 41
The prostate stromal transcriptome in aggressive and lethal prostate cancer 39
Molecularly defined tumour microenvironment ecosystems enhance prognostic stratification in low- and intermediate-risk prostate cancer 39
Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer 38
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 37
ELOVL5 affects prostate cancer cell proliferation and modulates the AR pathway 35
Deciphering Complexity: The Molecular Landscape of Castration-Resistant Prostate Cancer 33
Is it TIME for the clinical stratification of HR+/HER2- breast cancer? 31
The role of TMPRSS2_ERG fusions in modulating tumor microenvironment in prostate cancer 29
Antibody-Based Multiplex Image Analysis: Standard Analytical Workflows and Artificial Intelligence Tools for Pathologists 20
Spatially organized lymphocytic microenvironments in high grade primary prostate tumors 9
Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities 9
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors 6
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry 6
Totale 4.556
Categoria #
all - tutte 15.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 5 24 15 10 3
2021/2022214 8 7 6 1 17 19 6 6 10 50 27 57
2022/2023375 41 52 48 14 25 44 3 23 82 1 38 4
2023/2024375 13 24 43 72 39 46 27 8 3 19 32 49
2024/20252.109 74 65 29 122 158 266 151 91 201 221 236 495
2025/20261.417 182 216 341 309 301 68 0 0 0 0 0 0
Totale 4.556